PriceTracker GLP-1
Loading the index…

Try

Find the cheapest for me
  • Is compounded semaglutide still legal?

    As of November 2026, FDA says semaglutide is not on its drug shortage list or the 503B bulks list, so pharmacies may compound it only under the ordinary limits of sections 503A and 503B; the shortage-era grace periods ended in 2025.

  • Is compounded tirzepatide still legal?

    As of November 2026, FDA says tirzepatide is not on its drug shortage list or the 503B bulks list, so pharmacies may compound it only under the ordinary limits of sections 503A and 503B; the shortage-era grace periods ended in March 2025.

  • Is there a GLP-1 shortage?

    As of November 2026, FDA's drug shortage database lists both semaglutide injection and tirzepatide injection as resolved; FDA declared the tirzepatide shortage over on Dec 19, 2024 and the semaglutide shortage over on Feb 21, 2025.

  • Does Medicare cover GLP-1s for weight loss?

    As of November 2026, Medicare covers Wegovy (injection or tablet), Foundayo and the Zepbound KwikPen for weight loss through the temporary Medicare GLP-1 Bridge, for eligible people with Part D, at a $50 monthly copayment.

  • Is the Wegovy pill available?

    As of November 2026, the Wegovy pill (oral semaglutide) is sold with a prescription through Novocare home delivery at $149 a month for 1.5 mg, $199 for 4 mg and $299 for 9 mg and 25 mg self-pay, and Medicare's GLP-1 Bridge covers the tablet.

One email a week.

The cheapest GLP-1 program and any real price moves.

Compare every GLP-1